Source: Annual Congress 2007 - The role of gene polymorphisms in pulmonary disease susceptibility
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
E. Choi, M. J. Na, J. W. Son (Daejon, Republic Of Korea). DNA methylation marker for NSCLC and adjacent normal lung tissue using NotI-MseI methylation chip. Eur Respir J 2007; 30: Suppl. 51, 881

Member's Comments

No comment yet.

Related content which might interest you: DNA methylation markers of surfactant proteins in lung cancer Source: Annual Congress 2007 - Novel mediators of cellular pathology Year: 2007 DNA methylation is associated with lung function levels in never-smokers Source: International Congress 2017 – Epigenetics of lung function Year: 2017 Hypermethylation pattern in genomic DNA samples derived from tumor and serum of resected non-small cell lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 674s Year: 2004 DNA methylation and histone modifications of susceptibility in COPD and lung cancer Source: Annual Congress 2011 - Why is epigenetics important for lung disease? Year: 2011 DNA methylation and lung function: an epigenome-wide association study Source: International Congress 2017 – Epigenetics of lung function Year: 2017 Aberrant promoter methylation of CDH13 and MGMT genes is associated with clinicopathological characteristics of primary non small cell lung carcinoma Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 Profile of WT1 methylation in human lung cancer Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 Evaluation of promoter hypermethylation in tissue and blood of non-small cell lung cancer patients and association with survival. Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018 Loss of heterozygosity detected in plasma DNA of early stage lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 673s Year: 2004 p16INK4a promoter hypermethylation in tissue, blood, and sputum from non-small cell lung cancer and pulmonary inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 813s Year: 2006 RARβ2 methylation level in blood for lung cancer assessment Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011 LATE-BREAKING ABSTRACT: Comparison of methylation profiles in human blood and lung tissue identifies tissue specific CpG methylation sites Source: Annual Congress 2013 –Genetics and genomics of lung disease Year: 2013 Recognition of aberrant promoter methylation for early diagnosis of lung cancer patients Source: Virtual Congress 2020 – Screening and early lung cancer Year: 2020 Co-methylation analysis in lung tissue identifies pathways for fetal origins of COPD Source: Eur Respir J, 56 (4) 1902347; 10.1183/13993003.02347-2019 Year: 2020 DNA methylation and gene expression changes in human lung fibroblasts occur already in mild COPD and progress with disease development Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 PTGER4, a promising novel DNA methylation marker for lung cancer measured in a clinical case control study using blood plasma Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008 Detection of aberrant methylation of p16(INK4a) and MGMT in endobronchial specimens increases the diagnostic yield in cases of suspected peripheral lung carcinomas Source: Eur Respir J 2002; 20: Suppl. 38, 2s Year: 2002 SHOX2 DNA methylation is a promising biomarker for the diagnosis of lung cancer in plasma Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer Year: 2011 Aberrant promoter methylation in sputum and bronchial washing in patients at risk for lung cancer Source: Annual Congress 2009 - Genetics in the smokers corner: from inflammation in smokers via COPD to cancer Year: 2009